Discussions

The transfer information on solana.fm stopped updating and The API has also stopped outputting data.

Ace Therapeutics, a leading innovator in preclinical research models, has unveiled a suite of customizable in vivo and in vitro models designed to accelerate Alzheimer’s disease (AD) drug development. With neurodegenerative disorders posing a growing global health challenge, Ace Therapeutics’ advanced platforms provide researchers with highly predictive, translatable tools to evaluate novel therapeutics more efficiently.

Ace Therapeutics, a leading innovator in preclinical research models, has unveiled a suite of customizable in vivo and in vitro models designed to accelerate Alzheimer’s disease (AD) drug development. With neurodegenerative disorders posing a growing global health challenge, Ace Therapeutics’ advanced platforms provide researchers with highly predictive, translatable tools to evaluate novel therapeutics more efficiently.

Ace Therapeutics, a leading preclinical research organization, unveils its specialized nephrology-focused preclinical solutions to accelerate kidney disease drug development. With a comprehensive suite of validated models and cutting-edge technologies, Ace Therapeutics empowers researchers and biopharma companies to overcome challenges in renal drug discovery and translation.

The Tools Drop down has a link named Developer Portal that should contain my API. I am signed in under my wallet but when I click the link, it yields "

سلام و درود.

Biofilms, complex communities of microorganisms encased in a self-produced extracellular matrix, are notorious for their resilience and resistance to conventional antimicrobial therapies. They are a significant cause of chronic infections and pose a substantial challenge in clinical settings, particularly in patients with implantable devices or compromised immune systems. Biofilms cause resistance to many antimicrobial agents. The result of indwelling biofilms on medical devices is recurring, untreatable infections and medical device failure. To overcome chronic and recurrent infections, it is important to detect microbial biofilms and determine their antimicrobial susceptibility. In addition, identifying genes involved in biofilm formation and measuring gene expression due to anti-biofilm and antibacterial activity of agents may be beneficial in biofilm research.

C. elegans has long been a workhorse of genetic studies owing to its simple anatomy, sequenced genome, and rapid life cycle. Nevertheless, there has been a dearth of high-quality C. elegans genotyping tools, which has hindered experimental accuracy and reproducibility. CD BioSciences addresses this gap with its C. elegans Lysis Kits, which provide streamlined protocols and robust kits that ensure superior performance in C. elegans genotyping.

The Synthetic Biology Platform is a comprehensive toolbox and fully integrated platform to empower synthetic biology research and development.